Decitabine/lutetium-(177Lu)-oxodotreotide/temozolomideVarious toxicities

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2002卷 / 1期

关键词：

D O I：

10.1007/s40278-024-55535-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：158 / 158

相关论文

共 50 条

[1] Capecitabine/lutetium-(177Lu)-oxodotreotide/temozolomideVarious toxicities: 5 case reports
Reactions Weekly, 2021, 1858 (1) : 98 - 98
[2] Capecitabine/lutetium-(177Lu)-oxodotreotide/temozolomideVarious toxicities and lack of efficacy: 10 case reports
Reactions Weekly, 2023, 1963 (1) : 146 - 146
[3] Lutetium-(177Lu)-oxodotreotideVarious toxicities
Reactions Weekly, 2024, 1999 (1) : 230 - 230
[4] Denosumab/Lutetium-(177Lu)-oxodotreotide/OctreotideLack of efficacy
Reactions Weekly, 2024, 1998 (1) : 186 - 186
[5] Lutetium-(177Lu)-oxodotreotide/VandetanibTreatment failure: case report
Reactions Weekly, 2025, 2052 (1) : 245 - 245
[6] Amlodipine/lutetium-(177Lu)-oxodotreotide/sunitinibLack of efficacy and various toxicities: case report
Reactions Weekly, 2024, 2035 (1) : 41 - 41
[7] Lanreotide/lutetium-(177Lu)-oxodotreotide/octreotideLack of efficacy and haematological toxicity
Reactions Weekly, 2023, 1986 (1) : 233 - 233
[8] Lutetium (177Lu) oxodotreotide (Lutathera)
胡浩
宫平
中国药物化学杂志, 2018, 28 (05) : 435 - 435
[9] Lutetium-(177Lu)-oxodotreotideThrombocytopenia
Reactions Weekly, 2024, 2009 (1) : 357 - 357
[10] Capecitabine/lutetium-(177lu)-oxodotreotide/temozolomidePersistent haematologic toxicity: case report
Reactions Weekly, 2022, 1887 (1) : 170 - 170

← 1 2 3 4 5 →